UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042287
Receipt number R000048276
Scientific Title Factual investigation of Portoplumonary hypertension in chronic liver disease
Date of disclosure of the study information 2020/10/29
Last modified on 2021/02/24 19:48:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Factual investigation of Portoplumonary hypertension in chronic liver disease

Acronym

Factual investigation of Portoplumonary hypertension in chronic liver disease

Scientific Title

Factual investigation of Portoplumonary hypertension in chronic liver disease

Scientific Title:Acronym

Factual investigation of Portoplumonary hypertension in chronic liver disease

Region

Japan


Condition

Condition

Chronic liver disease, Portoplumonary hypertension

Classification by specialty

Hepato-biliary-pancreatic medicine Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the clinical course of portal hypertension and the clinical course of diagnosed portal hypertension in patients with chronic liver disease.

Basic objectives2

Others

Basic objectives -Others

Observational study

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

the prevalence of PoPH in Japanese patients with chronic liver disease

Key secondary outcomes

the etiology of PoPH in Japanese patients with chronic liver disease
the overall 5-year survival rate


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients over 20 years of age who have been diagnosed with chronic liver disease in our hospital and present with clinical symptoms (e.g., chest pain, dyspnea, syncope, blood sputum, etc.) that are suspicious of PoPH.
(2) Patients diagnosed with portal hypertension who can be followed up in our hospital.

Key exclusion criteria

(1)Cases for which follow-up was not possible at our hospital
(2) Any other cases that the researcher deems inappropriate.

Target sample size

2500


Research contact person

Name of lead principal investigator

1st name Shunichi
Middle name
Last name Wakabayashi

Organization

Shinshu university

Division name

Department of Internal Medicine, Division of Gastroenterology

Zip code

390-08621

Address

3-1-1, Asahi, Matsumoto, Japan

TEL

0263-37-2634

Email

ninai@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Shunichi
Middle name
Last name Wakabayashi

Organization

Shinshu university

Division name

Department of Internal Medicine, Division of Gastroenterology

Zip code

390-08621

Address

3-1-1, Asahi, Matsumoto, Japan

TEL

0263-37-2634

Homepage URL


Email

ninai@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu university

Institute

Department

Personal name



Funding Source

Organization

Shinshu University Faculty of Medicine, Department of Gastroenterology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University Ethics Committee

Address

3-1-1, Asahi, Matsumoto, Japan

Tel

0263-37-2572

Email

mdrinri@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

信州大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 09 Month 17 Day

Date of IRB

2020 Year 09 Month 28 Day

Anticipated trial start date

2020 Year 10 Month 29 Day

Last follow-up date

2025 Year 09 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study


Management information

Registered date

2020 Year 10 Month 29 Day

Last modified on

2021 Year 02 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048276


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name